Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
8.59
+0.02 (0.18%)
At close: Sep 5, 2025, 4:00 PM
8.58
-0.01 (-0.06%)
After-hours: Sep 5, 2025, 4:00 PM EDT
Y-mAbs Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$13.91
Upside
+62.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $11 → $8.6 | Strong Buy → Hold | Downgrades | $11 → $8.6 | +0.17% | Aug 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $26 → $8.6 | Strong Buy → Hold | Downgrades | $26 → $8.6 | +0.17% | Aug 6, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $20 → $15 | Buy | Maintains | $20 → $15 | +74.72% | May 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +28.13% | May 19, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +63.08% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +132.96% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $12 | Strong Buy | Maintains | $22 → $12 | +39.78% | Mar 21, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +39.78% | Mar 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +109.67% | Mar 5, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $11 → $7 | Sell | Maintains | $11 → $7 | -18.46% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +156.26% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +98.02% | Dec 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +167.91% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +156.26% | Nov 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.